Synthetic Futures | GenomeWeb

Synthetic Futures

The synthetic biology sector is starting to gain steam, as humankind gets closer to achieving its long-held ambitions to hack into the natural world and make it work for us, and more investors start to arrive on the scene, according to Entrepreneur.

Developments in recent years have made it more likely that companies can use synthetic biology tools to produce new products like materials, biofuels, flavors, drugs, and fragrances, among others, Britt Wray writes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.